Top

Published in:

01-02-2014 | Original Research

Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and Caregivers

Authors: Karina Sakanaka, Cheryl H. Waters, Oren A. Levy, Elan D. Louis, Wendy K. Chung, Karen S. Marder, Roy N. Alcalay

Published in: Journal of Genetic Counseling | Issue 1/2014

Abstract

The purpose of the study is to investigate Parkinson disease (PD) patients’ and caregivers’ knowledge of and interest in genetic testing. Gaucher disease (GD) results from recessive mutations in glucocerebrosidase (GBA). Both heterozygote GBA carriers and GD patients are at greater risk for PD. Studies regarding knowledge of and interest in genetic testing have been limited and have not offered genetic results to participants. In this study, 353 PD patients and 180 caregivers were recruited to a PD genetic study. The association between GD, GBA mutations and PD was described to participants who reported their familiarity with genetic terms, answered questions on genetic concepts, and indicated their interest in knowing if they may have GD (two GBA mutations) and other genetic information that could impact their health. Ninety-three-percent of participants were interested in receiving GBA results; however, only 51.6 % of PD participants and 55.6 % of caregivers knew that “scientists have identified genes associated with a higher risk of developing PD.” PD patients may benefit from education and genetic counseling on the implications of genetic testing.

Aharon-Peretz, J., Rosenbaum, H., et al. (2004). Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. The New England Journal of Medicine, 351(19), 1972–1977.PubMedCrossRef

Anheim, M., Elbaz, A., et al. (2012). Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology, 78(6), 417–420.PubMedCrossRef

Bekris, L. M., Mata, I. F., et al. (2010). The genetics of Parkinson disease. Journal of Geriatric Psychiatry and Neurology, 23(4), 228–242.PubMedCentralPubMedCrossRef

Bluman, L. G., Rimer, B. K., et al. (1999). Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. Journal of Clinical Oncology, 17(3), 1040–1046.PubMed

Bluman, L. G., Rimer, B. K., et al. (2003). Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses. Psycho-Oncology, 12(5), 410–427.PubMedCrossRef

Butters, T. D. (2007). Gaucher disease. Current Opinion in Chemical Biology, 11(4), 412–418.PubMedCrossRef

Catz, D. S., Green, N. S., et al. (2005). Attitudes about genetics in underserved, culturally diverse populations. Community Genetics, 8(3), 161–172.PubMedCrossRef

Creighton, S., Almqvist, E. W., et al. (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington’s disease: the experience in Canada from 1987 to 2000. Clinical Genetics, 63(6), 462–475.PubMedCrossRef

Dahodwala, N., Connolly, J., et al. (2007). Interest in predictive testing for Parkinson’s disease: impact of neuroprotective therapy. Parkinsonism & Related Disorders, 13(8), 495–499.CrossRef

Falcone, D. C., Wood, E. M., et al. (2011). Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest. Journal of Genetic Counseling, 20(4), 384–395.PubMedCentralPubMedCrossRef

Gan-Or, Z., Giladi, N., et al. (2008). Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology, 70(24), 2277–2283.PubMedCrossRef

Harper, P. S., Lim, C., et al. (2000). Ten years of presymptomatic testing for Huntington’s disease: the experience of the UK Huntington’s Disease Prediction Consortium. Journal of Medical Genetics, 37(8), 567–571.PubMedCrossRef

Henneman, L., Timmermans, D. R., et al. (2004). Public experiences, knowledge and expectations about medical genetics and the use of genetic information. Community Genetics, 7(1), 33–43.PubMedCrossRef

Jacobs, H., Latza, U., et al. (2001). Attitudes of young patients with Parkinson’s disease towards possible presymptomatic and prenatal genetic testing. Genetic Counseling, 12(1), 55–67.PubMed

Knoppers, B. M., Joly, Y., et al. (2006). The emergence of an ethical duty to disclose genetic research results: international perspectives. European Journal of Human Genetics, 14(11), 1170–1178.PubMedCrossRef

McInerney-Leo, A., Hadley, D. W., et al. (2005). Genetic testing in Parkinson’s disease. Movement Disorders, 20(1), 1–10.PubMedCrossRef

Nasreddine, Z. S., Phillips, N. A., et al. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.PubMedCrossRef

Ozelius, L. J., Senthil, G., et al. (2006). LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. The New England Journal of Medicine, 354(4), 424–425.PubMedCrossRef

Quaid, K. A., & Morris, M. (1993). Reluctance to undergo predictive testing: the case of Huntington disease. American Journal of Medical Genetics, 45, 41–45.CrossRef

Rana, H. Q., Balwani, M., et al. (2013). Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genetics in Medicine, 15(2), 146–149.PubMedCentralPubMedCrossRef

Ravitsky, V., & Wilfond, B. S. (2006). Disclosing individual genetic results to research participants. The American Journal of Bioethics, 6(6), 8–17.PubMedCrossRef

Semaka, A., & Balneaves, L. G. et al. (2012). “Grasping the grey”: patient understanding and interpretation of an intermediate allele predictive test result for huntington disease. Journal of Genetic Counseling 22(2), 200–217.

Sidransky, E., Nalls, M. A., et al. (2009). Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. The New England Journal of Medicine, 361(17), 1651–1661.PubMedCentralPubMedCrossRef

Tan, E. K., & Jankovic, J. (2006). Genetic testing in Parkinson disease: promises and pitfalls. Archives of Neurology, 63(9), 1232–1237.PubMedCrossRef

Tan, E. K., Lee, J., et al. (2007). Comparing knowledge and attitudes towards genetic testing in Parkinson’s disease in an American and Asian population. Journal of the Neurological Sciences, 252(2), 113–120.PubMedCrossRef

Velayati, A., Yu, W. H., et al. (2010). The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders. Current Neurology and Neuroscience Reports, 10(3), 190–198.PubMedCentralPubMedCrossRef

Wooten, G. F., Currie, L. J., et al. (2004). Are men at greater risk for Parkinson’s disease than women? Journal of Neurology, Neurosurgery, and Psychiatry, 75(4), 637–639.PubMedCrossRef

Title: Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and Caregivers
Authors: Karina Sakanaka
Cheryl H. Waters
Oren A. Levy
Elan D. Louis
Wendy K. Chung
Karen S. Marder
Roy N. Alcalay
Publication date: 01-02-2014
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 1/2014
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-013-9618-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and Caregivers

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Expansion of Genetic Services Utilizing a General Genetic Counseling Clinic

Newborn Screening: Education, Consent, and the Residual Blood Spot. The Position of the National Society of Genetic Counselors

Perceived Versus Predicted Risks of Colorectal Cancer and Self-Reported Colonoscopies by Members of Mismatch Repair Gene Mutation-Carrying Families Who Have Declined Genetic Testing

NSGC 2014 Presidential Address: Just Own It

Predictive Genetic Testing of a Bone Marrow Recipient–Ethical Issues Involving Unexpected Results, Gender Issues, Test Accuracy, and Implications for the Donor

Molecular Testing for Cystic Fibrosis Carrier Status Practice Guidelines: Recommendations of the National Society of Genetic Counselors